Dr. Xiaolong Yang has received a three-year research grant from Canadian Breast Cancer Foundation (CBCF)

2012 May 03

Dr. Xiaolong Yang has received $449,100 for a three-year research grant from Canadian Breast Cancer Foundation (CBCF) to study the roles of several novel genes in chemotherapeutic drug resistance of breast cancer.

Breast cancer is the most frequently diagnosed cancer in women worldwide and is responsible for one third of all cancer deaths of women in Canada. One of the difficulties encountered in breast cancer therapy is that breast cancer patients are usually either intrinsically resistant to chemotherapeutic drugs or acquire resistance after initial treatment, which results in cancer recurrent following primary chemotherapy. The research findings from this project will not only has the potential to significantly advance our understanding of the molecular mechanism underlying drug resistance but also has great implication for the future development of novel therapeutic drugs for the successful treatment of drug-resistant breast cancer patients.

yang2012may